Johnson & Johnson Is Teaming Up With Its Rival to Make More Doses

The Biden administration brokered the deal between the two competitors

Johnson & Johnson’s one-shot Covid-19 vaccine was authorized for emergency use by the Food and Drug Administration on Saturday, but the bulk of its doses won’t be available until the end of March. Manufacturing delays have stalled production of the vaccine at the company’s plant in Baltimore.

More on Johnson & Johnson’s vaccine:

Read up on the details of the third vaccine available in the United States:

A real-time resource for news, advice, and commentary brought to you by Medium.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store